Cargando…

Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review

Tuberous sclerosis complex (TSC) is a rare autosomal dominant neurocutaneous syndrome. It is manifested mainly in cutaneous lesions, epilepsy and the emergence of hamartomas in several tissues and organs. The disease sets in due to mutations in two tumor suppressor genes: TSC1 and TSC2. The authors...

Descripción completa

Detalles Bibliográficos
Autores principales: Jurca, Claudia Maria, Kozma, Kinga, Petchesi, Codruta Diana, Zaha, Dana Carmen, Magyar, Ioan, Munteanu, Mihai, Faur, Lucian, Jurca, Aurora, Bembea, Dan, Severin, Emilia, Jurca, Alexandru Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957184/
https://www.ncbi.nlm.nih.gov/pubmed/36833359
http://dx.doi.org/10.3390/genes14020433
_version_ 1784894763760091136
author Jurca, Claudia Maria
Kozma, Kinga
Petchesi, Codruta Diana
Zaha, Dana Carmen
Magyar, Ioan
Munteanu, Mihai
Faur, Lucian
Jurca, Aurora
Bembea, Dan
Severin, Emilia
Jurca, Alexandru Daniel
author_facet Jurca, Claudia Maria
Kozma, Kinga
Petchesi, Codruta Diana
Zaha, Dana Carmen
Magyar, Ioan
Munteanu, Mihai
Faur, Lucian
Jurca, Aurora
Bembea, Dan
Severin, Emilia
Jurca, Alexandru Daniel
author_sort Jurca, Claudia Maria
collection PubMed
description Tuberous sclerosis complex (TSC) is a rare autosomal dominant neurocutaneous syndrome. It is manifested mainly in cutaneous lesions, epilepsy and the emergence of hamartomas in several tissues and organs. The disease sets in due to mutations in two tumor suppressor genes: TSC1 and TSC2. The authors present the case of a 33-year-old female patient registered with the Bihor County Regional Center of Medical Genetics (RCMG) since 2021 with a TSC diagnosis. She was diagnosed with epilepsy at eight months old. At 18 years old she was diagnosed with tuberous sclerosis and was referred to the neurology department. Since 2013 she has been registered with the department for diabetes and nutritional diseases with a type 2 diabetes mellitus (T2DM) diagnosis. The clinical examination revealed: growth delay, obesity, facial angiofibromas, sebaceous adenomas, depigmented macules, papillomatous tumorlets in the thorax (bilateral) and neck, periungual fibroma in both lower limbs, frequent convulsive seizures; on a biological level, high glycemia and glycated hemoglobin levels. Brain MRI displayed a distinctive TS aspect with five bilateral hamartomatous subependymal nodules associating cortical/subcortical tubers with the frontal, temporal and occipital distribution. Molecular diagnosis showed a pathogenic variant in the TSC1 gene, exon 13, c.1270A>T (p. Arg424*). Current treatment targets diabetes (Metformin, Gliclazide and the GLP-1 analog semaglutide) and epilepsy (Carbamazepine and Clonazepam). This case report presents a rare association between type 2 diabetes mellitus and Tuberous Sclerosis Complex. We suggest that the diabetes medication Metformin may have positive effects on both the progression of the tumor associated with TSC and the seizures specific to TSC and we assume that the association of TSC and T2DM in the presented cases is accidental, as there are no similar cases reported in the literature.
format Online
Article
Text
id pubmed-9957184
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99571842023-02-25 Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review Jurca, Claudia Maria Kozma, Kinga Petchesi, Codruta Diana Zaha, Dana Carmen Magyar, Ioan Munteanu, Mihai Faur, Lucian Jurca, Aurora Bembea, Dan Severin, Emilia Jurca, Alexandru Daniel Genes (Basel) Case Report Tuberous sclerosis complex (TSC) is a rare autosomal dominant neurocutaneous syndrome. It is manifested mainly in cutaneous lesions, epilepsy and the emergence of hamartomas in several tissues and organs. The disease sets in due to mutations in two tumor suppressor genes: TSC1 and TSC2. The authors present the case of a 33-year-old female patient registered with the Bihor County Regional Center of Medical Genetics (RCMG) since 2021 with a TSC diagnosis. She was diagnosed with epilepsy at eight months old. At 18 years old she was diagnosed with tuberous sclerosis and was referred to the neurology department. Since 2013 she has been registered with the department for diabetes and nutritional diseases with a type 2 diabetes mellitus (T2DM) diagnosis. The clinical examination revealed: growth delay, obesity, facial angiofibromas, sebaceous adenomas, depigmented macules, papillomatous tumorlets in the thorax (bilateral) and neck, periungual fibroma in both lower limbs, frequent convulsive seizures; on a biological level, high glycemia and glycated hemoglobin levels. Brain MRI displayed a distinctive TS aspect with five bilateral hamartomatous subependymal nodules associating cortical/subcortical tubers with the frontal, temporal and occipital distribution. Molecular diagnosis showed a pathogenic variant in the TSC1 gene, exon 13, c.1270A>T (p. Arg424*). Current treatment targets diabetes (Metformin, Gliclazide and the GLP-1 analog semaglutide) and epilepsy (Carbamazepine and Clonazepam). This case report presents a rare association between type 2 diabetes mellitus and Tuberous Sclerosis Complex. We suggest that the diabetes medication Metformin may have positive effects on both the progression of the tumor associated with TSC and the seizures specific to TSC and we assume that the association of TSC and T2DM in the presented cases is accidental, as there are no similar cases reported in the literature. MDPI 2023-02-08 /pmc/articles/PMC9957184/ /pubmed/36833359 http://dx.doi.org/10.3390/genes14020433 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Jurca, Claudia Maria
Kozma, Kinga
Petchesi, Codruta Diana
Zaha, Dana Carmen
Magyar, Ioan
Munteanu, Mihai
Faur, Lucian
Jurca, Aurora
Bembea, Dan
Severin, Emilia
Jurca, Alexandru Daniel
Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review
title Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review
title_full Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review
title_fullStr Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review
title_full_unstemmed Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review
title_short Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review
title_sort tuberous sclerosis, type ii diabetes mellitus and the pi3k/akt/mtor signaling pathways—case report and literature review
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957184/
https://www.ncbi.nlm.nih.gov/pubmed/36833359
http://dx.doi.org/10.3390/genes14020433
work_keys_str_mv AT jurcaclaudiamaria tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview
AT kozmakinga tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview
AT petchesicodrutadiana tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview
AT zahadanacarmen tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview
AT magyarioan tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview
AT munteanumihai tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview
AT faurlucian tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview
AT jurcaaurora tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview
AT bembeadan tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview
AT severinemilia tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview
AT jurcaalexandrudaniel tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview